miércoles, 7 de octubre de 2026
BuscarExplore
es.VIA.NEWS
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 10, 2026

Tech stocks today: Nvidia CEO Jensen Huang blogs about AI's impact, Anthropic sues Defense Department over ban

View original at finance.yahoo.com
Tech stocks today: Nvidia CEO Jensen Huang blogs about AI's impact, Anthropic sues Defense Department over ban Artificial intelligence continues to make waves in markets, spurring new investments and concerns each week…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Nvidia is investing $30 billion in OpenAI

    80% confidence

  • Seeking judicial review does not change longstanding commitment to harnessing AI to protect national security, but is necessary step to protect business, customers, and partners

    80% confidence

  • Broadcom achieved record Q1 revenue on continued strength in AI semiconductor solutions

    80% confidence

  • Q1 AI revenue of $8.4 billion grew 106% year over year, driven by robust demand for custom AI accelerators and AI networking

    80% confidence

  • The promise of prediction markets is to harness the wisdom of the crowd to create accurate, unbiased forecasts for the most important events to society

    80% confidence

  • The opportunity to invest $100 billion in OpenAI is probably not in the cards because they're going to go public, and this might be the last time to invest in a company like this

    80% confidence

  • Every company and country will participate in the AI build-out

    80% confidence

  • AI isn't just about a single model, but represents the largest infrastructure build-out in human history, spanning industries from energy to software

    80% confidence

  • Nvidia's $10 billion investment in Anthropic will probably be the last

    80% confidence

  • AI is a five-layer cake comprising energy, chips, infrastructure, models, and applications

    80% confidence

  • Federal agencies should immediately cease all use of Anthropic's technology

    80% confidence

  • Small amounts of H200 products for China-based customers were approved by US government, but Nvidia has yet to generate any revenue and doesn't know whether any imports will be allowed into China

    80% confidence

  • AI revenue growth is accelerating and company anticipates Q2 segment revenue of $10.7 billion

    80% confidence

  • Anthropic has no choice but to challenge the DOD designation in court

    80% confidence

Citado en estos reportajes de Via News

Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
Nuestra lectura de los datos ›
Señales que seguimos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,986
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,986 hechos verificados con la fuente5,362 documentos fuente archivados
Consulta estos datos → isubstrate.com
Tech stocks today: Nvidia CEO Jensen Huang blogs about AI's impact, Anthropic sues Defense Department over ban — Source | Via News | es.VIA.NEWS